These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1517354)

  • 41. Monotherapy in advanced prostate cancer: an overview.
    Baltogiannis D; Giannakopoulos X; Charalabopoulos K; Sofikitis N
    Exp Oncol; 2004 Sep; 26(3):185-91. PubMed ID: 15494685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hormonal treatment in biochemical recurrence after radical prostatectomy].
    Antolín AR; Ojeda JM; Otero JR; Rodríguez AC; Castellano D; Esteban MD; Sicilia LD; González RD
    Arch Esp Urol; 2012; 65(1):111-21. PubMed ID: 22318183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostate cancer--treatment of disseminated disease.
    Abi-Aad AS; Opsomer RJ
    Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
    [No Abstract]   [Full Text] [Related]  

  • 44. Percentage of positive biopsy cores at the onset of hormone therapy for prostate cancer: prognostic significance.
    Normand G; Celhay O; Briffaux R; Pirès C; Doré B; Fromont G; Irani J
    Urol Int; 2009; 83(2):160-5. PubMed ID: 19752610
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Maximal androgen ablation: a review.
    Miles BJ; Babiarz J
    Henry Ford Hosp Med J; 1992; 40(1-2):114-7. PubMed ID: 1428961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine therapy of prostate cancer: optimal form and timing.
    Labrie F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1066-71. PubMed ID: 7714068
    [No Abstract]   [Full Text] [Related]  

  • 47. [Osteoporosis in castration therapy--a neglected field].
    Bratt O; Akesson K
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1902-5. PubMed ID: 22111227
    [No Abstract]   [Full Text] [Related]  

  • 48. Endocrine treatment: expected duration stage by stage.
    Schröder FH
    Prostate Suppl; 2000; 10():26-31. PubMed ID: 11056490
    [No Abstract]   [Full Text] [Related]  

  • 49. Complete hormonal blockage--antiandrogens.
    Bierkens AF; Debruyne FM
    Acta Urol Belg; 1996 May; 64(2):77-9. PubMed ID: 8701818
    [No Abstract]   [Full Text] [Related]  

  • 50. Hormonal therapy in prostatic carcinoma.
    Resnick MI
    Urology; 1984 Nov; 24(5 Suppl):18-23. PubMed ID: 6388092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer, gonadal hormones, and my brain.
    Wassersug RJ
    J Sex Marital Ther; 2014; 40(5):355-7. PubMed ID: 24846435
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hormonotherapy for prostate cancer].
    Oishi K; Yoshida O
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2300-5. PubMed ID: 8259842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of advanced cancer of the prostate.
    Orovan WL
    Can J Surg; 1989 Sep; 32(5):315-6. PubMed ID: 2670160
    [No Abstract]   [Full Text] [Related]  

  • 55. Guidelines on the management of prostate cancer.
    Ago CT
    Clin Oncol (R Coll Radiol); 1999; 11(5):361. PubMed ID: 10591828
    [No Abstract]   [Full Text] [Related]  

  • 56. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.
    Chertin B; Spitz IM; Lindenberg T; Algur N; Zer T; Kuzma P; Young AJ; Catane R; Farkas A
    J Urol; 2000 Mar; 163(3):838-44. PubMed ID: 10687989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total androgen ablation: American experience.
    Crawford ED; Nabors WL
    Urol Clin North Am; 1991 Feb; 18(1):55-63. PubMed ID: 1899495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The current state of hormonal therapy for prostate cancer.
    Hellerstedt BA; Pienta KJ
    CA Cancer J Clin; 2002; 52(3):154-79. PubMed ID: 12018929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent progress in the treatment of advanced prostatic cancer.
    Saini A; Waxman J
    Br J Hosp Med; 1992 Jan 23-Feb 4; 47(2):122, 125-6. PubMed ID: 1543959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?
    Krahn M; Bremner KE; Tomlinson G; Luo J; Ritvo P; Naglie G; Alibhai SM
    BJU Int; 2011 Nov; 108(10):1588-96. PubMed ID: 21453344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.